https://ba.prisysbiotech.com/ Ne - Ljudski Primate Istraživanje Platforma & CRO | PRISYS Biotech https://ba.prisysbiotech.com/uploads/39406/logo.png https://ba.prisysbiotech.com/biosafety-research/ Biosafety Research https://ba.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://ba.prisysbiotech.com/nhp-pharmacology/ NHP Pharmacology https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://ba.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://ba.prisysbiotech.com/safety-evaluation/ Safety Evaluation https://ba.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://ba.prisysbiotech.com/translation-research/ Translation Research https://ba.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://ba.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://ba.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://ba.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://ba.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://ba.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://ba.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://ba.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://ba.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://ba.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://ba.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://ba.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://ba.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://ba.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://ba.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://ba.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://ba.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://ba.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://ba.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://ba.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://ba.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://ba.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://ba.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://ba.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://ba.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ba.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://ba.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://ba.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://ba.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://ba.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://ba.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://ba.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://ba.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://ba.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://ba.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://ba.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://ba.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ba.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://ba.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://ba.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://ba.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://ba.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://ba.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://ba.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://ba.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://ba.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://ba.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://ba.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://ba.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://ba.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ba.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://ba.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://ba.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://ba.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://ba.prisysbiotech.com/pk-pd-adme/adme.html ADME https://ba.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://ba.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://ba.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://ba.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://ba.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://ba.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://ba.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://ba.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ba.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://ba.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://ba.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://ba.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://ba.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://ba.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://ba.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://ba.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://ba.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://ba.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://ba.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://ba.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://ba.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://ba.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://ba.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://ba.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://ba.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://ba.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://ba.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://ba.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://ba.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://ba.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://ba.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://ba.prisysbiotech.com/translation-research/clinical-imaging.html Clinical Imaging https://ba.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://ba.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://ba.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://ba.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://ba.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://ba.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://ba.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://ba.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://ba.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Model dijabetes melitusa tipa 2 https://ba.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Model dijabetes melitusa tipa 2 https://ba.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://ba.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://ba.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://ba.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://ba.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://ba.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://ba.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://ba.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://ba.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://ba.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://ba.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://ba.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://ba.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://ba.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://ba.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://ba.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://ba.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://ba.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://ba.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://ba.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://ba.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://ba.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://ba.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://ba.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://ba.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://ba.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://ba.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://ba.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://ba.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://ba.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://ba.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://ba.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://ba.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://ba.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://ba.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://ba.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://ba.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://ba.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://ba.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://ba.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://ba.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://ba.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://ba.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://ba.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://ba.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://ba.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://ba.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://ba.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://ba.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://ba.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://ba.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://ba.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://ba.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://ba.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://ba.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://ba.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://ba.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://ba.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://ba.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://ba.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18002955929117696.html Molekularna slika u NHP modelima za razvoj translacionog lijeka https://ba.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://ba.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968134094939136.html NHP BehaviorAtlas Webinar|3D NHP praćenje ponašanja za razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://ba.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724208134693888.html Rekapitulacija 2025: Kako Prisys redefinira translacionu pouzdanost u istraživanju NHP-a https://ba.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://ba.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17555460205224960.html NHP - Farmakologija i farmakodinamičke usluge sa sjedištem u NHP-u|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528841362629632.html Upoznajte Pririsys Biotech na nadolazećim EU Roadshow: septembar 2025. godine https://ba.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://ba.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17447964097995776.html Prisys Biotech - 2025. pregled sredinom godine https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245532409619456.html Upoznajte Prisijeve u predstojećem nas-Roadshowu u martu 2025. godine https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84036157.html PRISYS godišnji izvještaj 2024: Unapređenje NHP modela i pretkliničkih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://ba.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77721111.html Prisys Biotech 2024 Q2 Newsletter - Unaprijeđeno pretkliničko istraživanje i razvoj za CNS terapeutike s PRISYS unakrsno reaktivnim modelima https://ba.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://ba.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028051793601536.html Zašto životinjski modeli uspijevaju ili ne uspijevaju u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021125917320192.html Kvantitativni PET ciljni angažman u NHP za CNS lijekove https://ba.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://ba.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014970073179136.html Od videa do podataka: 3D AI praćenje za NHP ponašanje https://ba.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://ba.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015047031186432.html Snimanje biodistribucije PET kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://ba.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18002948194558976.html PBPK Vs. Kompartmentalni modeli: Zašto je PBPK bitan https://ba.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://ba.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993009247593472.html Rekapitulacija webinara: Unapređenje translacionog NHP istraživanja kroz digitalnu fenotipizaciju ponašanja https://ba.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://ba.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990249713198080.html PK biomarkeri u pretkliničkom razvoju lijekova|Izloženost – odgovor i PK/PD https://ba.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://ba.prisysbiotech.com/news/behavior-in-rhesus-17983363272156160.html Spontano samopovređivanje-ponašanje kod rezus makaka: translacioni NHP model za razvoj neuropsihijatrijskih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://ba.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983363153798144.html MIDD i NHP modeli efikasnosti u razvoju translacionih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://ba.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973462879200256.html AI-3D NHP analiza ponašanja|Fenotipizacija ponašanja bez markera https://ba.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://ba.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973462749586432.html Globalni webinar|Kvantifikacija složenih NHP ponašanja: predstavljanje NHP BehaviorAtlasa za visoko{0}}verno 3D fenotipiziranje ponašanja https://ba.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://ba.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968134193980416.html AI-Powered NHP bihevioralna analiza za pretklinički razvoj lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://ba.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973462987121664.html Kada uvesti NHP studije u razvoj autoimunih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://ba.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973463202522112.html NHP IBD modeli: čemu nas uči kronični enterokolitis kod rezus makaka o translacijskoj upali crijeva https://ba.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://ba.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973462607094784.html MRI-Vođena AAV isporuka u NHP modelima mozga za CNS gensku terapiju https://ba.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://ba.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973463051248640.html Zašto su lijekovi pozitivne kontrole važni u modelima autoimunih bolesti|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://ba.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973467297850368.html Osnovni ADA skrining kod ispranih-majmuna za pretkliničke biološke studije https://ba.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://ba.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968134172894208.html Mehanizmi boli: UVB model opekotina od sunca je vitalni alat za prevođenje https://ba.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://ba.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968134098723840.html NHP modeli programiranja dijete sa visokim-masnim sadržajem kod majke i pretilosti kod djece https://ba.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://ba.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17946413552395264.html Tumačenje kliničke patologije kod pasa i neljudskih primata u pretkliničkim studijama https://ba.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://ba.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17946428423382016.html Biomarkeri molekularne slike: unapređenje translacionog istraživanja i razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://ba.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17946413560914944.html Šta je nelinearna farmakokinetika? Mehanizmi, karakteristike i implikacije za razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://ba.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17946413745284096.html Zašto je NHP molekularna slika kritična za translacijske PET studije https://ba.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://ba.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17946413872964608.html Šta je molekularna slika i zašto je važna u razvoju lijekova? https://ba.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://ba.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17946413811164160.html NHP studije biodistribucije radionuklida: molekularna slika za translacioni razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://ba.prisysbiotech.com/news/nhp-heart-failure-model-17946413499130880.html NHP model srčane insuficijencije podržava translacijska istraživanja genske terapije za obnavljanje telomera https://ba.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://ba.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17946410941228032.html Kako DSA i CTA imaging poboljšavaju procjenu sigurnosti lijekova za kardiovaskularne bolesti https://ba.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://ba.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17946409776636928.html NHP model arteriovenske šant tromboze kod Cynomolgus majmuna za translacionu procjenu antitrombotičkog lijeka https://ba.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://ba.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888683008844800.html Farmakokinetički podaci kao translacioni biomarker https://ba.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://ba.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888683218674688.html Ne-modeli plućne fibroze kod primata: unapređenje translacijske tačnosti u razvoju respiratornih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://ba.prisysbiotech.com/news/nhp-models-translational-drug-development-17888681889801216.html Zašto razvoj lijekova sve više ovisi o NHP modelima|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://ba.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888682013582336.html PK podaci kao farmakodinamički biomarker: unapređenje translacionog razvoja lijekova kroz kvantitativnu farmakologiju https://ba.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://ba.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17861156994327552.html Ne-GLP farmakološke studije za podnošenje propisa: integritet podataka i laboratorijski zahtjevi https://ba.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://ba.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17861134076486656.html Strateški dizajn nekliničkih farmakokinetičkih studija: od ADME profiliranja do translacionog odlučivanja-Donošenje https://ba.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://ba.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17861144975074304.html NHP AV-Model tromboze šanta za procjenu sigurnosti lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://ba.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17861134201168896.html Šta je nelinearna farmakokinetika? Mehanizmi i translaciona PK evaluacija|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://ba.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17861134635082752.html Prisys Biotech podržava IND odobrenje UX-GIP001 od strane FDA i CDE|NHP CNS platforma za isporuku https://img01.v15cdn.com/gallery/4x3/157.webp https://ba.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17861134582260736.html In vivo praćenje imunoloških ćelija i razvoj PET tragača u NHP modelima|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://ba.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17861133840163840.html Dopamine Transporter PET Imaging u NHP modelima|CNS Imaging|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://ba.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17861133605577728.html PET/CT biodistribucija u NHP modelima za isporuku lijekova CNS|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://ba.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17861133710681088.html Velika-platforma za radio-obilježavanje životinja i in vivo slikovna platforma za razvoj translacijskih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://ba.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17861133735535616.html Zašto se razvoj lijekova sve više oslanja na NHP modele: suštinska uloga primata u translacijskoj medicini|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://ba.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17861133722772480.html Izazovi i rješenja IPF-a u razvoju lijekova|NHP modeli sa CT snimanjem i PFT https://ba.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://ba.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17861133550380032.html NHP 3D sistem za analizu ponašanja bez markera za pretklinička istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://ba.prisysbiotech.com/news/evaluating-dmpk-properties-17861133697115136.html Procjena svojstava DMPK spojeva kandidata u ranom otkrivanju lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://ba.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17861123117409280.html MRI-Vođena isporuka CNS-a u NHP modelima|Translacijska IMRI & CED platforma https://ba.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://ba.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17861123509724160.html NHP CNS studije biodistribucije|Intratekalna dostava RNK|PRISYS Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://ba.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17861124086113280.html Translacijski PK/PD okvir: Cynomolgus Monkey To Human Dose Prediction|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://ba.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724211855959040.html Kada bol postane sjećanje: emocionalni pokretači kroničnog bola i prednost NHP modela|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://ba.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724211816047616.html Više-Procjena bola u krajnjoj tački: budućnost razvoja analgetičkih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://ba.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724209139000320.html Zašto toliko analgetika ne uspije u pretkliničkim ispitivanjima? Odgovor leži u tome kako mjerimo bol https://ba.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://ba.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724206769021952.html Dizajn vremenske tačke uzorkovanja krvi u farmakokinetičkim (PK) studijama|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://ba.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724206741054464.html PK statistika: Parametri bez-kompartmentalne analize (NCA) i pretkliničke primjene https://ba.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://ba.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724206303896576.html Zašto su modeli ne-ljudskih primata kritični za CNS oligonukleotidnu terapiju https://ba.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://ba.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724206259528704.html Metabolizam mokraćne kiseline kod ljudi protiv majmuna: translacijske implikacije za razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://ba.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724205995353088.html Ne-MASH-model pridružene fibroze jetre|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://ba.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724206207738880.html Zašto je IMRI{0}}navođena isporuka lijekova za mozak ključna za precizno ciljanje u NHP studijama https://ba.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://ba.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674622059439104.html NHP 3D sistem za analizu ponašanja bez markera|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://ba.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674622088897536.html LPS-indukovana akutna upala pluća (ALI) NHP model|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://ba.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674622124712960.html HDM+SEB-Model induciranog atopijskog dermatitisa (AtD) kod Cynomolgus majmuna https://ba.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://ba.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674626702664704.html Objašnjenje PK modela sa jednim- do više-odjeljaka|NHP Pharmacokinetics|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://ba.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674626422547456.html Kako odabrati pouzdanu pretkliničku CRO|Ključni kriterijumi za biotehnološke kompanije|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://ba.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674622005470208.html Translacijska CAR-T evaluacija: In Vitro ekspertiza i podrška studijama NHP — Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://ba.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674622184580096.html Zašto više od 90% kandidata za lijekove za CNS ne uspije u kliničkim ispitivanjima? https://ba.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://ba.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674622611317760.html Pretklinički modeli Parkinsonove bolesti: Vodič za odabir neurotoksina, genetskih i NHP modela|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://ba.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674622114538496.html Visoko{0}}precizne isporuke lijekova i NHP platforme za prevođenje vođene AI{1}} https://ba.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://ba.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625188821148672.html NHP imunološki modeli vođeni Th17|Translacijska autoimunska istraživanja u Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://ba.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625189014381568.html NHP BehaviorAtlas® sistem zasnovan na AI- 3D platforma za analizu ponašanja|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://ba.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625190657991680.html RFP šablon za NHP studije|Ubrzajte efikasnost pretkliničkih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://ba.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625189873984512.html Model bola pri hladnoj alodiniji u Cynomolgus Monkeys|Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://ba.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625188888781824.html MRI-Vođena platforma za intracerebralnu isporuku lijekova|Prisys Biotech CNS Research https://ba.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://ba.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625189711586304.html NHP modeli respiratornih bolesti i platforma za isporuku lijekova u disajnim putevima|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://ba.prisysbiotech.com/news/nhp-renal-biopsy-17625189200782336.html NHP platforma za biopsiju bubrega i modeli bubrežne bolesti|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://ba.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625189180040192.html PK studije i ciljana isporuka lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://ba.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625188964852736.html NHP Research and AI-bazirana platforma za analizu ponašanja Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://ba.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625189889156096.html Tehnologija isporuke iz nosa-u-mozak (N2B) za istraživanje CNS-a|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://ba.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625188730659840.html SHR-2004: Proboj u prevenciji VTE za pacijente s rakom jajnika – priča o uspjehu Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://ba.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538079422735360.html Cynomolgus & Rhesus Monkey Models|Prisys Biotech Preclinical CRO https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528841183060992.html Idiopatska plućna fibroza (IPF) NHP model|Prisys Biotech preklinički CRO https://ba.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528841352913920.html Cynomolgus Monkey Biodistribution Studies|Prisys Biotech Preclinical CRO https://ba.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://ba.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528841455133696.html Prisys BIOTECH NHP modeli za hematologiju i istraživanje hoda https://ba.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://ba.prisysbiotech.com/news/the-importance-of-administration-volume-17528841231115264.html Važnost volumena administracije u pretkliničkim studijama|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://ba.prisysbiotech.com/news/brain-targeted-drug-delivery-17528841258165248.html Mozak - ciljana dostava droga|Prisys Biotech preklinički NHP Istraživanje https://ba.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://ba.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528879861244928.html ADC Drug Development|Translacioni PK/PD okvir u pretkliničkim NHP studijama https://ba.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://ba.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17496371874505728.html NHP modeli boli za prelazni lijek otkriće|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://ba.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17496372141908992.html Serum Vs. Plazma: Odabir optimalne matrice za pretkliničku bioanalizu https://ba.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://ba.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17496371800794112.html Smjernice za pretkliničko doziranje: IV & PO Volumen, PH i osmolarnost za tačan PK u NHP i drugim vrstama https://ba.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://ba.prisysbiotech.com/news/nhp-copd-model-17496371843638272.html Top COPD Istraživački modeli i izvrsnost respiratorne platforme od strane Prissa https://ba.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://ba.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17496371690775552.html NHP Akutni model krvarenja: ključni alat za ubrzavanje razvoja lijekova za ubrzavanje romana https://ba.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://ba.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17496371666560000.html Istraživanje Pruritus: PRISSY BIOTECHOV IL-31 IN-31 NHP model za ocjenu anti-svrbenih terapija https://ba.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ba.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17447964031329280.html Vodič za procjenu anti-antitijela na lijek (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17447964101960704.html Respiratorne terapije: Prisys Biotech-ova integrisana NHP platforma za pretklinička istraživanja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17447964024398848.html NHP modeli boli: ubrzanje analgetskog razvoja lijekova u Pririsy Biotech https://ba.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://ba.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17447986329428992.html Model NHP modela za podršku razvoju droga u složenim bolestima https://ba.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://ba.prisysbiotech.com/news/key-considerations-for-dosing-volume-17447963991827456.html Ključna razmatranja za volumen doziranja, PH i formulaciju u životinjskim modelima https://ba.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://ba.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17447963751343104.html Dizajnirani egzosomi: Revolucionarna isporuka lijekova za poremećaje CNS-a – pretklinički uvidi Prisys Biotech-a https://img01.v15cdn.com/gallery/4x3/300.webp https://ba.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17447963707974656.html Vodeći principi za selekciju životinjskih vrsta u studijama toksikologije lijekova nukleinske kiseline https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17447963857937408.html Prisys Biotech DSA i IMRI za hematološke, vaskularne i bubrežne studije https://ba.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17447963787289600.html Cynomolgus Monkey Pain Models: Pokretanje translacijskog istraživanja za probojnu terapiju jonskog kanala https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17447963947836416.html Istraživanje atopijskog dermatitisa: Prison BIOTECH-ov nečovječni primat (NHP) model https://ba.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://ba.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17447963724768256.html PRISSY BIOTECHOV NHP atopijski dermatitis model za razvoj lijekova protiv prurita https://ba.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://ba.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17387991795901440.html Dizajniranje studija na životinjama: Ključna razmatranja za uspjeh pretkliničkih istraživanja https://img01.v15cdn.com/gallery/4x3/300.webp https://ba.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17387991594427392.html Atopijski dermatitis: kako modeli Cynomolgus majmun avans preciznosti terapeutike https://ba.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://ba.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17387991477396480.html Istraživanje astme: zašto su modeli ne-ljudskih primata ključni za razvoj novih lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17387991449068544.html Razumijevanje farmakokinetike antisens oligonukleotida (ASO): ključni faktori u apsorpciji i distribuciji https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17387991724221440.html NHP inhalacijske studije za biološke lijekove: PRISYS-ove specijalizirane pretkliničke CRO usluge https://img01.v15cdn.com/gallery/4x3/300.webp https://ba.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17387991490913280.html Napredne pretkliničke studije inhalacije: tehničke mogućnosti i stručnost u Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ba.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17387991565755392.html Razumijevanje farmakokinetike (PK): ključni parametri i aplikacije u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://ba.prisysbiotech.com/news/intracerebroventricular-icv-injection-17387991793837056.html Intracerebroventrikularna (ICV) injekcija: precizna isporuka CNS-a za pretklinička istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://ba.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17387991692960768.html Intracerebralna (ICM) injekcija: precizno ciljanje za CNS terapeutike – pretklinička razmatranja https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17387991647839232.html Intratekalna (IT) injekcija: direktna ruta isporuke CNS-a za napredne terapije – pretklinička razmatranja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17387991411696640.html Unapređenje istraživanja Parkinsonove bolesti pomoću NHP modela https://img01.v15cdn.com/gallery/4x3/300.webp https://ba.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17387991654573056.html Pretkliničke PK/PD studije i NHP modeli za razvoj lijekova|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://ba.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17302883327534080.html Ciljanje na interleukin-31 (IL-31): nova granica u razvoju lijekova za autoimune bolesti – Prisys Biotech NHP modeli za pretklinička istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://ba.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17301885489521664.html Neklinička procjena imunotoksičnosti: strategija, ključna razmatranja i odabir metode https://img01.v15cdn.com/gallery/4x3/232.webp https://ba.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17301885333726208.html Testiranje na mikrobe i njegov utjecaj na ne-primate u pretkliničkim DMPK studijama https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17301885504414720.html Model endometrioze Cynomolgus Monkey za napredovanje terapijskog istraživanja https://ba.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://ba.prisysbiotech.com/news/membranous-nephropathy-model-17301885277299712.html Napredni razvoj lijekova za membransku nefropatiju (MN): Prisys Biotechova platforma Cynomolgus Monkey Model Platforma https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17301885393789952.html Farmakokinetika inhaliranih lijekova: promjena paradigme od sistemske do plućne izloženosti https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/animal-models-for-womens-health-17301885268157440.html Prisys Biotech: Animal Models For Women's Health Therapeutics https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17301920933585920.html Svjetski dan pretilosti|Prisys BIOTECH NHP metabolički modeli: Pokretanje razvoja anti-gozljačkih terapija za novu generaciju https://ba.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://ba.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17301885350798336.html Prisys Biotech's Cynomolgus Monkey Psoriasis model: Napredovanje prekliničke farmakodinamičke evaluacije https://ba.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://ba.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17301920713745408.html Integracija farmakokinetike i farmakodinamike u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://ba.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888682545275904.html Na-Webinar na zahtjev|Precizni most: MRI-navođeni CED i prevodivi NHP modeli za isporuku lijekova u CNS https://ba.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://ba.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17301885471548416.html Šta dokaz koncepta (PoC) u razvoju lijekova zaista potvrđuje? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17301885254607872.html Životinjski modeli|Izazovi i primjene u razvoju modela bola https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17301920912466944.html Noklinička farmakodinamička istraživanja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245532641453056.html Odabir idealnog ne-primata za toksikološke studije: Cynomolgus Macaque, Rhesus Macaque i Marmoset https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120834.html Ciljana terapija za Parkinsonovu bolest: proboj u-MRI u realnom vremenu-vođenoj transplantaciji matičnih ćelija https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17301885352764416.html Sistemski eritematozni lupus (SLE) i uloga životinjskih modela u terapijskom razvoju https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17301885348078592.html Ne-ljudski sloj primat za reumatoidni artritis (RA) https://ba.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://ba.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17301885350634496.html Stereotaktički instrumenti za životinjski mozak bazirani na 3D koordinatnim sistemima https://ba.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://ba.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17301885369836544.html Životinjski modeli za in vivo testiranje (1): uspostavljanje i klasifikacija https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84036218.html Istraživanje potencijalnih puteva za ulazak bioloških tvari u mozak https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84036161.html Unapređenje istraživanja reumatoidnog artritisa (RA) s modelima primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://ba.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84036158.html Istraživanje životinjskih modela za efikasnost lijekova za atopijski dermatitis https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84036231.html Kritična uloga životinjskih modela u istraživanju ljudskih bolesti https://ba.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://ba.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84036237.html Model majmuna s nedostatkom Parkin gena otkriva nove mehanizme i terapeutske ciljeve za Parkinsonovu bolest https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84036169.html Neklinički vodič za razvoj lijekova: akutne, subakutne, subkronične i kronične studije opće toksičnosti https://ba.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://ba.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84036155.html Inovativna isporuka lijekova iz nosa u mozak (N2B): zaobilaženje krvno-moždane barijere https://ba.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://ba.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84036156.html Mogućnosti i izazovi mini svinja kao nekliničke vrste velikih životinja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83095944.html Strategije isporuke lijekova za bolesti mozga https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83095904.html Intraoperativna MR navigacija u realnom vremenu: podrška odobrenju FDA za prvu gensku terapiju za nedostatak AADC https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83095898.html Studije očne toksičnosti kapi za oči: izloženost lijekovima i procjena sigurnosti https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82797888.html Prisys Biotech uspostavlja model psorijaze kod majmuna Cynomolgus kako bi ubrzao razvoj lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82797893.html Sveobuhvatni modeli ne-ljudskih primata za istraživanje bubrežnih bolesti od strane Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82797895.html Sveobuhvatna pretklinička procjena sigurnosti konjugata antitijela-lijekova (ADC) kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82797884.html Farmakokinetička procjena konjugata antitijela-lijekova (ADC) kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82797883.html Farmakodinamička evaluacija ADC https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82797890.html Razumijevanje DMPK ADC lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82797887.html Napredak u razvoju lijekova nukleinskih kiselina i istraživačke sposobnosti Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82332900.html Napredak u sistemima plućne isporuke mRNA i inovativnim uslugama Prisys biotech https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82797889.html Zašto je 2024. Nobelova nagrada za fiziologiju ili medicinu dodijeljena ova dva naučnika koji su proučavali mikroRNA? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82797896.html Farmakokinetička (PK) razmatranja za lijekove za centralni nervni sistem (CNS). https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656481.html Napredak u istraživanju CNS-a: Prisys Biotech-ov MRI-kompatibilan sistem ubrizgavanja u mozak i CED tehnologija https://ba.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120826.html Unapređenje terapeutskih inovacija za krvarenje i zgrušavanje s Cynomolgus Monkey MCAO modelom https://ba.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://ba.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81120825.html DMPK evaluacija lijekova za centralni nervni sistem (CNS). https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/animal-models-of-human-diseases-81120830.html Životinjski modeli ljudskih bolesti https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120817.html Inovacije u evaluaciji bola: AI{0}}analiza ponašanja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/china-experimental-monkey-industry-81120819.html Istorija, trenutni status, izazovi i mogućnosti kineske eksperimentalne industrije majmuna https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/human-disease-animal-models-81120823.html Životinjski modeli ljudskih bolesti: ključni alat za unapređenje biomedicinskih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81121206.html Važnost pretkliničke farmakodinamike u razvoju lijekova|Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://ba.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120821.html Intranazalna primjena u studijama na životinjama https://ba.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://ba.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410583.html Revolucioniranje razvoja CNS lijekova: PRISYS Biotech uvodi IMRI tehnologiju https://ba.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://ba.prisysbiotech.com/news/convection-enhanced-delivery-81120824.html Napredak precizne medicine: Konvekcija-Tehnologija poboljšane isporuke (CED) od Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81120822.html Cynomolgus majmun kronična bolest bubrega (CKD) model Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://ba.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79526971.html Predklinička procjena sigurnosti primjene lijekova u oči pomoću Cynomolgus Macaques https://ba.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://ba.prisysbiotech.com/news/compartment-pk-model-81120827.html Razumijevanje modela odjeljka i ne{0}}kompartmenta u farmakokinetici https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120818.html Napredne tehnike isporuke CNS-a kod Cynomolgus majmuna: ubrzanje razvoja oligonukleotidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://ba.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79526978.html Smanjenje upotrebe neljudskih primata u nekliničkim procjenama sigurnosti: perspektive FDA i industrije https://ba.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://ba.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79527022.html LCMS pretklinička bioanaliza lijekova za gensku terapiju baziranih na LNP-u https://ba.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://ba.prisysbiotech.com/news/mrna-based-therapies-past-79527017.html MRNA{0}}bazirane terapije: prošlost https://ba.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://ba.prisysbiotech.com/news/pk-strategies-of-pdc-79526968.html Strategije farmakokinetičkih studija peptidnih{0}}konjugata lijekova (PDC) https://ba.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://ba.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79527026.html Uloga AAV-a u genskoj terapiji: imunološki odgovori i toksičnost https://ba.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://ba.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79526974.html Optimizirane strategije nekliničke evaluacije imunogenosti https://ba.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://ba.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79527014.html Farmakodinamička (PD) evaluacija genske terapije https://ba.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527000.html Farmakokinetika i bioanaliza oligonukleotidnih lijekova-(1) https://ba.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79527021.html Farmakokinetika i bioanaliza oligonukleotidnih lijekova: karakteristike apsorpcije i farmakokinetike plazme (PK) https://ba.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://ba.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79527019.html Faktori koje treba uzeti u obzir za imunogenost oligonukleotidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://ba.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79527024.html MRNA: Snažan i svestran alat za borbu protiv bolesti-Prisys-Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://ba.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79527004.html Kineski naučnici nude nove strategije za preokretanje osnovnih simptoma Parkinsonove bolesti https://ba.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://ba.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79526999.html Prisys biotehnologija: nove lipidne nanočestice za isporuku MRNA kod primata https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79526997.html Važnost istraživanja translacijske medicine od osnovnih istraživanja do kliničkih studija https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79527012.html Glavni faktori koji se razmatraju u analizi WOE https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79526992.html Kako dostaviti biološke lijekove u mozak? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79526996.html Kako se lijekovi kreću i mijenjaju u našim tijelima: Kratak uvod u farmakokinetiku https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79527001.html Kako brže i sigurnije razviti nove lijekove: Vodič za pretkliničke DMPK studije https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79527020.html Smjernice za grupni smještaj za laboratorijske majmune https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79527010.html Vitalna uloga eksperimentalnih majmuna u unapređenju naučnih istraživanja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79527013.html Razumijevanje Macaca Fascicularis (Cynomolgus Monkey): ključne karakteristike i doprinosi biomedicinskim istraživanjima https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79526998.html Revolucioniranje liječenja metaboličkih bolesti: Napredak i izazovi u razvoju peptidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79526995.html Kako procijeniti sigurnost proizvoda za kožu prije kliničkih ispitivanja? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79527009.html Značajna uloga eksperimentalnih majmuna u inovativnom razvoju lijekova: pogled iznutra na posao https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79527016.html Toksičnost jetre kao ključna briga za lijekove SiRNA: sveobuhvatna analiza Specifičnost cilja: mač s dvije oštrice{0}}SiRNA https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79526991.html Unapređenje terapije SiRNA: prevazilaženje izazova u razvoju lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79526981.html Izgledi primjene genskih lijekova na bazi lipidnih nanočestica https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79527006.html Ključne tačke u dizajniranju strategija za ne-kliničke studije na maloljetnim životinjama https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79526988.html Uvid u senzorne i bihevioralne osobine ne-ljudskih primata (NHP) https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79527015.html Pitanja i odgovori o evaluaciji predkliničkih studija https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/significance-principles-and-requirements-of-79527851.html Značaj, principi i zahtjevi sigurnosno-farmakološkog istraživanja https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79527835.html Kako procijeniti pretkliničku farmakološku efikasnost? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79527003.html Razmišljanja o ne-kliničkim farmakološkim studijama i evaluaciji terapijskih lijekova za ne-nealkoholni steatohepatitis (NASH) https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79526976.html Unapređenje istraživanja CNS-a i CGT-a: Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79526993.html Smjernice za prikupljanje cerebrospinalne tekućine koja nije-ljudska primata https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79526980.html Razmatranja za tumačenje podataka o kliničkoj patologiji kod neljudskih primata (NHP) i pasa https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79526970.html ​​​​​Integriranje procjene sigurnosti CNS-a u opće toksikološke studije https://ba.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://ba.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79526990.html Kako provesti pretkliničku farmakološku/toksikološku evaluaciju ADC-a? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526975.html ADME uvid u oligonukleotidne lijekove (1) - apsorpcija, distribucija https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79526985.html ADME uvid u oligonukleotidne lijekove (2) - Metabolizam i izlučivanje https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79526967.html Pretkliničke studije na životinjama (1) - životinjske vrste https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79526972.html Izazovi i strategije interpretacije podataka kliničke patologije u pretkliničkim studijama pasa i ne-primata https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79527005.html Pretkliničke studije na životinjama (2) - Rute i količine administracije https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/mrna-based-therapies-present-79527023.html MRNA{0}}bazirane terapije: prisutne https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79527018.html MRNA{0}}bazirane terapije: budućnost i izazovi https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79527007.html Kratak uvod o biološkoj analizi genske terapije https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410582.html Cynomolgus majmun u istraživanju oftalmoloških lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410584.html Translacijske i unakrsne-reaktivne studije s Prisysovim NHP modelima imunologije i upale https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79185738.html Ne-naivni NHP u pretkliničkim ispitivanjima: isplativo-isplativo rješenje Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/nhp-asthma-model-79185740.html NHP model astme: osnaživanje pretkliničkih studija efikasnosti lijekova uz Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79185737.html Napredak u istraživanju imunologije i upale s modelima Cynomolgus Macaques - Prisys Biotechnologies https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79185733.html Direktna isporuka oligonukleotidnih lijekova u CNS i uobičajene histopatološke promjene https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79185736.html Intra-model cerebrovaskularnog moždanog udara (ICH) Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75171612.html Ne-istraživanje farmakodinamike: bitan aspekt u razvoju lijekova SiRNA https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77721114.html MRI-Navođeni sistem precizne lokalizacije i isporuke centralnog nervnog sistema velikih životinja se smjestio u Prisys Biotech https://ba.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://ba.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77063225.html Inovativna rješenja za unapređenje respiratorne terapije https://ba.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://ba.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74804003.html Prisys: Unapređenje eksperimentiranja na životinjama kroz studije Cynomolgus Macaquea https://ba.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://ba.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76183587.html Prisys postiže punu akreditaciju od strane AAALAC International: prekretnica u osiguravanju visokih standarda njege laboratorijskih životinja. https://ba.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://ba.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74677650.html Podizanje terapije nukleinskim kiselinama kroz vrhunsku-ivicu uz Prisys Biotech modele neljudskih primata https://ba.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://ba.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74175477.html Revolucioniranje isporuke lijekova za CNS: Prisys i obećanje intratekalne injekcije https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75171609.html Prisys Biotech 2024 Q1 Newsletter - vaš pouzdani specijalista za studije neljudskih primata https://ba.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://ba.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73544250.html Kako ultrazvučna-navođena biopsija jetre poboljšava istraživanje zasnovano na makaku- https://ba.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://ba.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73544249.html Smjernice za doživotnu upotrebu neljudskih primata u biomedicinskim istraživanjima: Prisys biotehnološka perspektiva https://ba.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://ba.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73023878.html Ne-Primati: Kratak uvod u njihove biološke karakteristike https://ba.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://ba.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72679086.html Pregled izložbe|Prisys Biotech blista na godišnjem sastanku Američkog društva za neuronauku (SfN 2023) https://ba.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://ba.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321957.html Upoznajte Prisys Biotech na godišnjem sastanku Društva za neuronauku (SfN 2023) https://ba.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://ba.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321959.html Svjetski dan borbe protiv moždanog udara|Fokus na životinjske modele i farmakologiju ishemijskog moždanog udara https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321955.html Prisys Biotech vas poziva da prisustvujete godišnjem sastanku SAPA-Kina 2023. https://ba.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://ba.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321960.html Svjetski dan Alchajmerove bolesti|Izazovi i rješenja za razvoj AD lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321958.html Prisys Biotechov životinjski model Cynomolgus Macaque pomaže u razvoju novih antikoagulansa https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71069030.html Prisys: Pružanje visoko-kvalitetnih usluga eksperimenata na životinjama za novo antitelo protiv -faktora koagulacije XI BJTJ-1837 https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71069028.html Metoda za uspostavljanje modela hipertrigliceridemije Cynomolgus majmuna i njegova primjena https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71069031.html Farmakologija: glavni parametri i značaj farmakokinetike (PK) https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71069027.html Preklinička farmakološka evaluacija lijekova protiv onkolitičkih virusa https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/0-71069029.html Kako lijekovi male nukleinske kiseline mogu transformirati liječenje bolesti CNS-a: Uvidi iz Prisys biotehnologije, dobavljača NHP modela bolesti https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71069032.html Farmakokinetika, istraživačke strategije i studije slučaja peptidnih lijekova https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69666129.html Ključne tačke istraživanja ADC Drug PK https://img01.v15cdn.com/gallery/4x3/148.webp https://ba.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69657523.html Prisys Biotechnology: Lider u NHP CNS platformi za modeliranje bolesti https://ba.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://ba.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309409.html Kako smršaviti i kontrolisati dijabetes uz GLP-1 proizvode https://ba.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://ba.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309388.html Kako kineski majmun pomaže u provođenju predkliničkih istraživanja efikasnosti? https://ba.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://ba.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309275.html Koja je efikasnost RNAi? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309368.html Prisys Biotech Platforma javnih usluga za velike eksperimente na životinjama: niske-cijene i visoke-rješenje za velike eksperimente na životinjama https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69015520.html Kako AAV genska terapija može spasiti vaš vid: Najnovija otkrića iz studija koje nisu{0}}ljudi primati https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69015391.html Prisys Biotech predstavlja platformu za modele neljudskih primata na godišnjem sastanku Japanskog društva za toksikologiju https://ba.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://ba.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69018283.html Obećavajuća budućnost AAV genske terapije kod primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69017706.html Šta su lipidne nanočestice za gensku terapiju? https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69015625.html Prisys Biotech vas poziva da učestvujete na 50. godišnjem sastanku Japanskog društva za toksikologiju (JSOT) https://ba.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://ba.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69018386.html Test imunotoksičnosti, procjena sigurnosti lijekova-PRISYS BIOTECH https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306711.html Optimalni životinjski model ishemijskog moždanog udara utvrđen digitalnom subtrakcionom angiografijom-vođenim autolognim trombi u Cynomolgus majmuna https://ba.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://ba.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68116090.html Zašto biste trebali brinuti o ne-primatima u istraživanju i razvoju sistema za isporuku nukleinskih kiselina https://ba.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://ba.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68116088.html Upoznajte Prisys Biotech na 70. JALAS-u 2023! https://ba.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://ba.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68116954.html Genska terapija blista s novim odobrenjima za rijetke bolesti https://ba.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://ba.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68116089.html Revolucioniranje otkrića droga: Kako primati koji nisu ljudi optimiziraju SiRNA skrining za brže i efikasnije rezultate https://ba.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://ba.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67550071.html Maksimiziranje farmakološke efikasnosti SiRNA uz istraživanje primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://ba.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67549433.html Kako neljudski primati mogu revolucionirati istraživanje SiRNA: sveobuhvatni vodič https://ba.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://ba.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67548171.html Obilježavanje Svjetskog dana laboratorijskih životinja: Zašto je Prisys posvećen promicanju zdravlja primata koji nisu ljudi https://ba.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://ba.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67552109.html Maksimiziranje CRISPR/Cas9 istraživačke efikasnosti uz modele neljudskih primata https://ba.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://ba.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67547576.html Oslobađanje terapeutskog potencijala: Zašto je ulaganje u lijekove nukleinske kiseline budućnost medicine https://ba.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://ba.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67562280.html Otključavanje potencijala neljudskih primata u poboljšanju otkrivanja ciljanih lijekova genskom terapijom https://ba.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://ba.prisysbiotech.com/news/world-parkinsons-disease-day-67546934.html Ujedinite se za Parkinsonovu bolest: Udruživanje ruku radi podizanja svijesti na Svjetski dan Parkinsonove bolesti https://ba.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://ba.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67548172.html Kako efikasno koristiti primate koji nisu ljudi u procjeni sigurnosti genske terapije https://ba.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://ba.prisysbiotech.com/news/gene-therapy-toxicology-66274458.html Toksikološko istraživanje genske terapije s Nonhuam Primate https://ba.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://ba.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66128263.html Sveobuhvatni vodič za provođenje DMPK studije za gensku terapiju https://ba.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://ba.prisysbiotech.com/news/gene-therapy-nhp-model-66127932.html Revolucioniranje medicinskog istraživanja: Proboj genske terapije u modelima bolesti neljudskih primata! https://ba.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://ba.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66127937.html Top 10 popularnih pitanja vezanih za gensku terapiju https://ba.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://ba.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66127939.html Prisys Biotech: farmakologija ne-ljudskih primata za gensku terapiju https://ba.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://ba.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66127547.html Podrška zdravlju žena: Pogled na endometriozu https://ba.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://ba.prisysbiotech.com/news/prisys-sot2023-66127548.html PRISYS i Taichu grupa sarađuju na izložbi SOT 2023 https://ba.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://ba.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66127542.html Da li su nam potrebne daljnje studije za procjenu bola? - NHP https://ba.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://ba.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66127545.html Pridružite nam se u obilježavanju Svjetskog dana divljih životinja https://ba.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://ba.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66127544.html Pokreće Prisys Shanghai NHP R&D centar, označavajući prekretnicu u farmaceutskom istraživanju i razvoju u Kini https://ba.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://ba.prisysbiotech.com/news/meetprisys-sot2023-66127543.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://ba.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg